Area of research
Pharmacology · Molecular Biology
Research interest
Research focused on Cancer research and FOXO1, with related work in PI3K/AKT/mTOR pathway, Class (philosophy), Homeobox protein NANOG. Notable publications include 'FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma', 'C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism', and 'Structural Revisions of a Class of Natural Products: Scaffolds of Aglycon Analogues of Fusicoccins and Cotylenins Isolated from Fungi'.
Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
Rest to Promote Learning: A Brain Default Mode Network Perspective
Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma
C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8
Structural Revisions of a Class of Natural Products: Scaffolds of Aglycon Analogues of Fusicoccins and Cotylenins Isolated from Fungi
Structural Revisions of a Class of Natural Products: Scaffolds of Aglycon Analogues of Fusicoccins and Cotylenins Isolated from Fungi